Eli Lilly news from FierceHealthcare
NewsHealth advocacy nonprofits rarely disclose drug industry ties
Nonprofits that influence health policy are getting money in the form of grants from the pharmaceutical industry, according to a study published in the American Journal of Public Health. But they're Read more...
Medical educators in Pennsylvania received at least $10 million from drug companies in 2009
Conflict-of-interest allegations aside, several Pittsburgh-area doctors and nurse educators are insisting that their work is not compromised despite data showing they were paid roughly $3.5 million Read more...
Lilly exec will explore links to industry at Harvard
An executive with Eli Lilly has accepted a job with Harvard Medical School that will entail studying the relationship between the school's researchers and the pharmaceutical industry. William Chin, Read more...
Generic drugmakers protest paying in for health reform
Looked at it one way, generic drug manufacturers are getting quite a break when it comes to financing health reform. Under the Senate Finance Committee bill approved last week, the hospital industry Read more...
CVS Caremark attacked for allegedly deceptive drug ads
In what was supposed to be a bit of routine business, CVS Caremark recently sent out a series of promotional mailings to doctors on behalf of a handful of major drugmakers, including Eli Lilly, Read more...
IOM slams practice of accepting pharma swag
Over the last 18 months or so, the political climate has gotten pretty darned unfriendly for doctors who chose to accept pharma money or gifts. In some cases their parent organizations have banned Read more...
Government plans investigation of devicemaker kickbacks to surgeons
Federal health officials and prosecutors are mounting an investigation designed to identify doctors how accept kickbacks from drug and devicemakers for using their products. The investigation focuses Read more...
Pfizer will disclose payments to health professionals
Pfizer has announced that it plans to make data on payments to healthcare professionals publicly available starting in early 2010, including not only physicians, but also researchers and research Read more...
Lilly to pay $1.4B to settle Zyprexa marketing charges
For some time now, advocates for seniors have complained that anti-psychotic drugs were being used to chemically restrain demented patients, leaving them sedated and unaware. Now one drugmaker, Eli Read more...
Eli Lilly to pay $62M to settle Zyprexa marketing charges
Pharmaceutical company Eli Lilly has agreed $62 million to 33 states to settle charges that it Read more...
| Press ReleasesCEOs Lead Cancer Fighting EffortLilly becomes the 100th employer accredited through the CEO Cancer Gold StandardTM CARY, N.C.--(BUSINESS WIRE)-- Eli Lilly and Co. became the 100th employer to receive CEO Cancer Gold Standard Read more >> REACH Health Announces Richard E. Otto as President and CEOATLANTA--(BUSINESS WIRE)-- REACH Health, Inc. today announced the appointment of Richard E. Otto as President and CEO. Mr. Otto brings to REACH more than 30 years of healthcare and life science Read more >> PatientPoint Further Strengthens Leadership Team with New Executive AppointmentsAs PatientPoint broadens focus from provider groups to include health plans and pharmacy benefit managers, new team members bring in-depth healthcare, technology, operations experience ORLANDO, Read more >> Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trial ReviewDUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/c84174/chronic_myelocytic) has announced the addition of GlobalData's new report "Chronic Myelocytic Read more >> Research and Markets: Tourette Syndrome Global Clinical Trials Review, Q1, 2011DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/3d55bf/tourette_syndrome) has announced the addition of GlobalData's new report "Tourette Syndrome Global Read more >> |
